Hemming Johansson
Papers
1
Total Citations
14
H-Index
1
About
Hemming Johansson is a clinical researcher whose work focuses on gynecologic oncology, particularly the long-term outcomes and quality-of-life considerations following surgical staging for endometrial cancer. His most notable contribution is the landmark RASHEC trial, a comprehensive study that systematically evaluated the risks of lymphedema, serious adverse events, and imaging findings one year after comprehensive surgical staging. This work, published in 2019 with 14 citations, provides critical evidence for balancing the diagnostic benefits of lymphadenectomy against its potential harms, directly informing clinical decision-making and patient counseling. Johansson’s research highlights the importance of survivorship care in oncology, emphasizing the need to understand and mitigate treatment-related morbidities. By shedding light on the real-world consequences of standard surgical procedures, his findings have helped shape guidelines for endometrial cancer management. For students and researchers, Johansson’s work exemplifies how rigorous clinical trials can translate into tangible improvements in patient outcomes, making him a key voice in the evolving field of gynecologic cancer care.
Research Focus
Key Achievements
Top Papers
- 1